• Immunic, Inc. (NASDAQ:IMUX) Receives Average Rating of "Buy" from Analysts

    来源: Buzz FX / 04 10月 2024 05:03:09   America/New_York


    Immunic, Inc. (NASDAQ:IMUX) Receives Average Rating of "Buy" from Analysts Written by MarketBeat October 4, 2024 Share Link copied to clipboard. Immunic, Inc. ( NASDAQ:IMUX - Get Free Report ) has received a consensus recommendation of "Buy
    Read more...
分享